US › Healthcare

Incannex Healthcare Ltd ADR (IXHL)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.97+1.37%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-3.9M
Profit YoY
+2.1%
EPS
$-0.49
EPS estimate
$-0.84

EPS came in at -0.49 against a street estimate of -0.84 — a beat of 41.7%.

Key statistics

Market cap
$35.2M
Forward P/E
3.8
P/B
0.47
Book value
$5.50
EPS (TTM)
$-16.62
52-week high
$27.69
52-week low
$2.49
50-day MA
$3.38
200-day MA
$6.82
Beta
2.81

Analyst view

with an average price target of $17.84.

Shareholding

Insiders
12.34%
Institutions
10.82%

Largest institutional holders

FundStake
Polar Asset Management Partners5.22%
Ghisallo Capital Management LLC1.36%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.1.25%
Murchinson Ltd.0.87%
Arete Wealth Advisors, LLC0.61%
LPL Financial Corp0.59%
UBS Group AG0.34%
AdvisorShares Investments, LLC0.20%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Incannex Healthcare Ltd ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.